Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Innovate Biopharmaceuticals	Novan	Provectus Biopharmaceuticals	Edesa Biotech	Seelos Therapeutics
Symbol	NASDAQ:INNT	NASDAQ:NOVN	OTCMKTS:PVCT	NASDAQ:EDSA	NASDAQ:SEEL
Price Information
Current Price	$0.58	$0.46	$0.04	$3.19	$1.12
52 Week Range	Buy	Buy	N/A	Buy	Buy
Beat the Market™ Rank
Overall Score	0.6	1.2	0.6	1.6	1.4
Analysis Score	0.0	3.3	0.0	0.0	3.5
Community Score	2.4	2.2	3.0	2.5	2.8
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.0	0.0	4.0	0.0
Earnings & Valuation Score	0.6	0.6	0.0	1.3	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	N/A	Buy	Buy
Consensus Price Target	$10.00	$1.00	N/A	$10.00	$5.33
% Upside from Price Target	1,624.14% upside	115.15% upside	N/A	213.48% upside	376.19% upside
Trade Information
Market Cap	$23.97 million	$34.05 million	$17.66 million	$28.53 million	$50.34 million
Beta	-0.39	-0.27	0.4	0.2	1.86
Average Volume	525,982	7,621,904	231,667	50,370	2,105,474
Sales & Book Value
Annual Revenue	N/A	$4.90 million	N/A	$210,000.00	$380,000.00
Price / Sales	N/A	7.16	N/A	134.59	132.48
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	($0.27) per share	($0.89) per share	($0.06) per share	$12.69 per share	N/A
Price / Book	N/A	-0.52	N/A	0.25	∞
Profitability
Net Income	$-27,050,000.00	$-30,640,000.00	$-6,920,000.00	$-5,030,000.00	$-51,260,000.00
EPS	N/A	($0.80)	N/A	N/A	N/A
Trailing P/E Ratio	N/A	N/A	0.00	N/A	0.00
Forward P/E Ratio	∞	N/A	∞	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	-594.59%	N/A	-766.98%	N/A
Return on Equity (ROE)	N/A	N/A	N/A	-83.42%	-373.33%
Return on Assets (ROA)	-234.42%	-53.34%	-448.70%	-72.66%	-159.01%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	N/A	N/A	N/A	N/A
Current Ratio	0.35%	1.99%	0.13%	12.83%	1.97%
Quick Ratio	0.35%	1.99%	0.13%	12.83%	1.97%
Ownership Information
Institutional Ownership Percentage	5.88%	23.06%	0.03%	0.05%	11.53%
Insider Ownership Percentage	7.90%	5.36%	4.50%	61.40%	7.60%
Miscellaneous
Employees	8	47	2	6	N/A
Shares Outstanding	41.33 million	75.47 million	390.69 million	8.86 million	44.95 million
Next Earnings Date	N/A	8/11/2020 (Estimated)	8/13/2020 (Estimated)	8/12/2020 (Estimated)	8/6/2020 (Estimated)
Optionable	Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources